After microbial invasion and tissue damage, a set of cytokines, including interleukin-Irx (IL-Ia), lL-l~, lL-6, lL-18 and tumor necrosis factor-a (TNF-a), and microbial and endogenous molecules named pathogen-associated molecular pattern (PAMPs) and damage-associated molecular pattern (DAMPs), are released from activated leukocytes and dead cells and bind to immune receptors to induce the innate and adaptive response. The intracellular signals induced by the multiprotein complex formed by the Toll-like receptors/Il--I receptors (TLRs), NOD-like receptors (NLRs) and tumor necrosis factor-a receptors (TNFRs) and their ligands and downstream effectors lead to the activation of NF-KB (NF-kappaB) and the interferon regulatory factor (IRF) transcription factors and thereby the synthesis of pro-and anti-inflammatory genes as well as pro-and anti-cell death genes. Depending on cell-intrinsic and extrinsic biochemical events elicited by an inflammatory response, the cells die via apoptosis, necrosis, pyroptosis or autophagy cell death program. This article resumes our current understanding of these processes and how they influence inflammation.
A large number of T and B cell lineages is produced daily and participates in the delicate checks and balances that control the immune response to pathogens and maintenance of tolerance to self, and thus inhibit autoimmune diseases caused by uncontrolled auto-reactive antibodies (1) . The neutrophils, macrophages, dendritic cells (DC), natural killer (NK), NKT cells, and cytotoxic T cells (CTLs) cells act as biological kamikazes to provide a rapid and immediate destruction of pathogens and spontaneous malignant cells. When the immune system is fighting pathogens, immune cells communicate with one another by release and respond to over 100 soluble factors known as cytokines. Since the discovery and cloning of the first cytokine, a monocyte-derived pyrogenic factor, named interleukin-l~(IL-I rJ) in 1984 by Charles Dinarello's group (2) and its role in fever and inflammation, a huge number of studies was carried out to dissect the intricate molecular mechanisms that control cytokine production, binding to their receptor and triggering signaling pathways that lead to their variety of biological effects into several lineages of innate and adaptive immune cells (3) . Notably in the studies of synthesis, processing of pro-form and secretion of active IL-I rJ, the IL-l rJ-converting enzyme (ICE) was discovered and it turned out to be the caspase-l, the first cysteinyl-aspartate protease of caspase family (4) , which is a key component of the inflammasomes (5) .
In the intervening time, we have learned of the central roles played by the various classes of transmembrane and intracellular immune receptors, namely pattern recognition receptors (PRRs) containing Leucine-Rich Repeats (LRRs), of which the most studied, are the Toll-like receptors (6) and NOD-like receptors (7) . These receptors are involved in sensing and recognition of the Pathogen-Associated Molecular Pattern (PAMPs) molecules, which are conserved chemical signatures only expressed by microbes. Some PRRs are involved in the recognition of the endogenous Damaged-Associated Molecular Pattern (DAMPs) molecules or alarmins, such as High Mobility Group Box I protein (HMGB I) and uric acid, which are released from activated leukocytes and death cells (8) (9) . PAMPS and DAMPs act together with cytokines, chemokines and peptide antibiotics in promoting early and late events of an innate and adaptive response. These studies prompt a new paradigm shift in understanding innate and adaptive response in the context of pathophysiological processes, such as chronic inflammation, in which cycles ofproliferation and death of immune cells are commonly observed as well as competition for survival factors between various immune cell types in the niche, in order to maintain the homeostatic regulation (I). It is still uncertain to what extent the many and overlapping functions of cytokines, microbial and death cell products impact on the molecular switcher of the genetic program specifying Th 17 and regulatory T cell fate (Treg) and thereby impairing the Thl or Th2 cell response (I). Overproduction of cytokines, PAMPs and DAMPs appears to restrict the growth of pathogens by fueling a potent immune response (8) (9) . However, in some situations, this response can be detrimental to the host and may contribute to autoimmune and autoinflammatory diseases (I). Nonetheless, in some contexts this could be a mechanism to prevent the initial proliferation of autoreactive cells, thus preventing autoimmune disease.
PRRs linking the innate and adaptive response
The host biological defense (referred as immunity) upon infection, disease, or other unwanted biological invasion involves both an innate (non-specific) and an adaptive (specific) response. Innate immunity is the first-line host-defense to pathogens such as bacteria, fungi, parasites, and virus (I). The majority of pathogens can be detected by conserved and unique structural microbial components such as polysaccharides and polynucleotides that differ little from one pathogen to another but are not found in the host. The immune cells recognize such molecules referred to as PAMPs through one or more of the pattern-recognition receptors. Most PRRs contain a ligand-sensing region referred as leucinerich repeats (LRRs). The phagocytic leukocytes, endothelial and mucosal epithelial cells and antigenpresenting cells and various tissues express PRRs message and proteins during the cell's response. PRR families include the family of the Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), C-type Lectins (CTLs), RNA-sensing RIG-Like Helicases (RLHs) and DNA sensors (5) (6) (7) . These PRRs share some molecular features and signaling pathways which are essential for their crosstalk during the mediation of an inflammatory response.
TLRs are a conserved group of type I integral membrane glycoproteins homologous to a Drosophila protein named Toll that has an essential role for embryonic development and innate immunity (6) . TLRs are expressed differently among the human immune cell types and especially in macrophages, monocytes and many subsets of dendritic cells (6) . TLRs expressed on plasma membrane (TLRI, TLR2, TLR4, TLR5, and TLR6) and on endosomal membranes of endoplasmic reticulum (TLR3, TLR7, and TLR9) contain the LRR domain which specifically interact with a rather diverse plethora of ligands, including bacterial flagellins, single strand (ss) RNA, double strand (ds) RNA, peptidoglycans and imidazoquinioline compounds (6) . Table I shows a partial list of Tl.Rvstimulating agents, their pathogenic sources and intracellular adaptors and transducers involved in their signaling cascades. The most important role of TLRs during an innate response is the initiation of biochemical cascades that lead to activation of the NF-KB transcription factor. The TLR signaling pathway can be classified into two branches; (i) the signaling protein myeloid differentiation primary response gene 88 (MyD88)dependent cascade, which results in activation ofNF-KB and the expression of pro-inflammatory genes, and (ii) the MyD88-independent pathway which activates lRF3 culminating in the expression of type I interferons (IFN-a and -~) and pro-inflammatory genes. All TLR use the MyD88-dependent pathway except TLR3, which predominantly utilizes the TIR domain-containing adapter-inducing IFN-~(TRIF), a MyD88-independent pathway, while TLR4 is unique as it uses both MyD88-dependent and TRIFdependent signaling pathways (6) . TLR4 requires another adaptor, TRAM, for activating TRIF (6) .
IL-l Rand IL-18R contain three extracellular immunoglobulin domains and one intracellular Toll/IL-IR homology (TIR) domain, which is the conserved intracellular domain of the IL-l Rand TLR receptor families (3) . After recognizing a specific signature in a PAMP molecule via LRR domain, the TLR intracellular TIR domain interacts with MyD88, TIRAP/Mal or TRIF, which are proteins sharing a similar TIR domain (3, 6) . Upon stimulation, MyD88, via its death domain, interacts with the death domain of serine/threonine kinase (IRAK) family. IRAKI and IRAK4 are activated by phosphorylation, leading to the dissociation of IRAKl from the receptor complex. IRAKI in tum interacts with the tumor necrosis factor receptorassociated factor (TRAF) family member TRAF6 and with TAKI (transforming growth factor-~ activated kinase). The activation of TAKl leads to the formation of the IKB kinase and NF-KB essential modulator complex (IKKlNEMO), compnsmg the catalytic subunits IKKa and IKK~and the regulatory IKKy subunit. The NF-KB transcription factors heterodimers consisting of p 105 precursor and Rei subunits are normally kept inactive in the cytoplasm by interaction with inhibitors called IKBs (l0). The phosphorylation and ubiquination of Ixls« induced by the SCF~-TRCP complex (consisting of Skpl, Cull and the F-box protein~), and thereby the proteasome-mediated degradation of IKBa, are required for NF-KB heterodimer (p50/RelA) activation and its translocation to the nucleus (10). The NF-KB then mediate the transcription of genes for cytokines such as IL-la and B, IL-6, IL-8, TNFa, IL-l2, IL-l5, IFN-a and -~, cyclooxygenases (COXl and COX2), inducible nitric oxide synthase (iNOS), chemokines, E-selectins, as well as genes for initiation of an adaptive immune response such as CD80, CD86 and CD40, among others (l0). TLR3 and TLR4, and TLR7 and TLR9 also activate IRF3 and IRF7, respectively, leading to the production of IFN-a and IFN-~in a cell-type-specific manner (6) .
These cascades and biochemical events are shown in Fig. 1 and further described along the text.
The generation and use of various genetically deficient mice of TLR receptors and adaptors have led to the identification of several components from bacteria, fungi and virus as well as synthetic products that are able to activate these receptors. For example, TLR2-/-and TLR6-/-mice are unresponsive to all lipoproteins. TLRl and TLR2 form heterodimers that function in sensing and recognition of bacterial triacylated lipopeptides (Pam3CSK4). TLR2 also heterodimerizes with TLR6 that then recognizes bacterial diacylated lipopeptides (Pam2CSK4). Experiments with TLR4-/-mice confirmed that TLR4 is a lipopolysaccharide (LPS) receptor, as indicated in previous studies using CH3/HeJ and C57BL/lOScCr mouse strains that are highly resistant to endotoxin-induced shock (6) . TLR4 recognizes LPS with the assistance of LPS-binding protein (LBP), a soluble plasma protein which carries LPS to the CD 14, a glycosylphosphatidylin ositol-linked LRR molecule, resulting in the MD2/ TLR4 complex. TLR4 is involved in the recognition of respiratory syncytial virus fusion proteins and cytotoxic drug taxol (6) . TLR5 recognizes flagellin from salmonellas and other flagellated bacteria (6) . A TLR9 knockout mouse model proved that this receptor plays a critical role in the immune response to viral and bacterial unmethylated DNA with CpG motifs which are infrequently found in the human genome. CpG repeats directly stimulate B cells, macrophages and DCs to secrete cytokines, in particular, IL-l2 and IL-l8. TLR7 and TLR8 play an important role in the innate antiviral immunity by recognizing viral single-stranded RNA within endocytic compartments (6) . TLR3 is involved in the recognition of polyinosinic polycytidylic acid (poly I:C), a synthetic dsRNA analog (6) . Poly I:C shows potential as an adjuvant for DC targeted vaccines. The number of compounds serving as activator of TLR platforms is expanding, and now includes a variety of synthetic compounds (12) (13) .
The role of TLR participation in the adaptive immune response to a variety of stimuli came with the experiments using MyD88 knockout mice. The immunization ofMyD88 knockout mice with various antigens mixed with Freund's does not produce as strong an adaptive response as that observed in wild-type mice. In these mice, the production of cytokines such as IL-ll3, TNF -u and IL-6 is almost completely abolished whereas the activity of regulatory T cells (Treg) is upregulated (6) . These experiments confirmed the potential role ofTLRs in auto-immune diseases and allergies. In fact, we know now that many diseases are associated with hyperactivation or loss ofTLRs or their transducers and adaptors, some of which are described in Table I and elsewhere (3, 6, (12) (13) .
In recent times, a number of studies has shown the essential role of TLR system in sensing and responding to DAMPs that are exposed or endogenously secreted by cells undergoing the different cell death pathways due to "sterile inflammation" (i.e. without evidence of infection) as well as dead cells induced by some chemotherapeutic compounds (8) (9) . Calreticulin (CTR), heat-shock proteins HSP-60, HSP-70 and HSP-90 are examples of DAMPs localized on plasma membrane; HMGB 1, SPlOO calcium binding proteins, uric acid, DNA, RNA, ATP, hyaluronic acid, fibronectin, fibrinogen and heparin sulphate are examples of DAMPs secreted with other pro-inflammatory molecules, including cytokines, monokines and antimicrobial peptides (8) (9) . HMGB 1 is a non-histone, chromatin-associated protein released by dying cells as results of injury or by monocytes, macrophages and NK cells (14) . HMGBI acts as a cytokine and activates macrophages as well as dendritic cells. HMGB 1 can interact with ssDNA, LPS, IL-ll3, and nucleosomes and amplifies TLR-mediated inflammatory responses possibly by binding to TLR2, TLR4, TLR9, ILl R, and the receptor for advanced glycation endproducts (RAGE) (8) (9) . HMGB I is also involved in tissue repair and regeneration and, more importantly, administration of antibodies against HMGBI can rescue mice from lethal sepsis (14) . It is proposed that DAMPs released during immunogenic cell death induced by oxaliplatin, doxorubicin, mitoxantrone, bortezomib and ionizing radiation are functionally important for increasing the immunogenicity of tumor antigens (9) . HSP-70, HSP-90 and ecto-CTR present in the membranes help the assembly of the antigen-presenting receptors such as CD9l, LOX 1 and CD40. This facilitates the uptake of antigens by DCs, which can stimulate clonal expansion of specific T cells (9) . Therefore, the pharmacological manipulation of TLRs with selective agonists is expected to increase the immune response to antigen vaccines while their inhibition with specific antagonists may prevent an inflammatory response. Some of these therapeutic strategies and compounds in development are described in detail elsewhere (12) (13) .
The NOD-like receptor family consists of more than 22 members, including neuronal apoptosis inhibitor protein (NALPS), ICE protease activating factor (lPAF) and NOD subfamily of cytoplasmic proteins, also referred to as CATERPILLER proteins (5, 7) . NLR family members are specialized in the recognition of a variety of molecular entities derived from intracellular pathogens. The NLR proteins form large, signal-induced cytosolic multiprotein complexes named inflammasome. This occurs after their interaction with virus and bacterial products that have entered into the cell through type III or IV secretion systems, pore-forming toxins and hostderived channels (5, 7) .
NODllNLCRl (also known as CARD4) and NOD21 NLCR2 (also known as CARD15) are proteins with structural homology to APAF-l. These proteins can recognize peptides derived from bacterial gram positive and negative wall peptidoglycans, y-D-glutamyl-meso-diaminopimelic acid (iE-DAP) and muramyl dipeptide (MDP). Upon recognition, both NODI and NOD2 self-oligomerize with RIP2, a threonine kinase, which then acts on the NF-KB activating complex. The NALP3 inflammasome is formed upon interaction of a wide range of ligands, including bacterial RNA, antiviral imidazoquinioline compounds R837 and R848, and trinitro-chlorobenzene, a contact sensitizer, and a large number of host-derived molecules including uric acid crystal, hyaluronan, elevated extracellular glucose and fibrillar amyloid-B peptide (5, 7) . Several bacteria that secrete pore-forming toxins, such as S. pneumoniae which produces pneumolysin, and B. anthracis which produces anthrolysin 0, as well as, the pore-forming agents nigericin, maitotoxin, and aero lysin can promote the activation of the NALP3 inflammasome (5, 7) . The release of K+ through these pores causes intracellular acidification which is a critical endogenous signal for the inflammasome activation. Moreover, it has been proposed that binding ofATP molecules to P2X 7 surface purinergic ion channel results in the opening of a pannexin-1 membrane pore and K+ efflux, leading to activation of inflammasomes. IPAFINLCR4 inflammasome is known to sense bacterial flagellin from gramnegative bacteria, such as Salmonella typhimurium, Shigella flexneri, and Pseudomonas aeruginosa (5, 7) . Direct injection offlagellin into the cytosol or via bacterial type III and IV secretion systems activate IPAF inflammasome in the macrophage (15) .
Many of the NLR molecules identified harbor a central nucleotide-binding and oligomerization domain (NACHT), which is commonly flanked by Cterminal leucine-rich repeats (LRRs), pyrin domain (PYD), acidic transactivating domain, or baculoviral inhibition of apoptosis protein repeat domain (BIR) and caspase recruitment domain (CARD) (3, 5, 7) . An adapter molecule referred to as the apoptosisassociated speck-like protein (ASC) contains a pyrin domain (PYD) and a CARD domain which mediate the interaction of NLRs with the pro-inflammatory caspases via the CARD-CARD interaction (3, 5, 7) . The pro-inflammatory caspases are comprised of caspase-1, -11 and -12 in the mouse and caspase-1, -4, and -5 in the human (16) . The CARD domain is essential for bringing two or more caspase zymogens sufficiently close to induce their autocatalytic activation inside the inflammasome (16) (17) . Once activated, caspase-1 promotes the cleavage of the IL-ll3 precursor as well as of the IL-18 precursor, into active cytokines, which are then released from secretory lysosomes or via cellular leakage (3). ILl binds to IL-IR and induces the same set of genes as does TLRs (3). Caspase-l activation can help in tissue repair and release of many proteins without sequence signal such as IL-I a. Caspase-l cleaves IL-33, but in this case, IL-33 is inactivated (3, 16) . Various proteins were proposed to interfere with inflammasome assembly and inflammatory caspase activation. COP-I, INCA, ICEBERG and truncated caspase-12 are CARD-only proteins structurally similar to caspase-1 molecule and as such play an important role as physiological inhibitors of caspase-1 activation within the inflammasome complex (16) . A selected set of diseases associated with loss or deficiency of NLR family members, adaptors and transducers are summarized in Table I and described in details elsewhere (3, 5, 7, 12) .
Links between irflammasomes, pyroptosis and autophagy
Recently, many inflammasome platforms containing intracellular engulfed bacterial and viral molecules have been described by their ability to induce pyroptosis which is a pro-inflammatory and cell death program dependent on caspase-l activation (18) (19) . Pyroptosis is typically observed in infected macrophages, monocytes and dendritic cells. It has been considered a cell death modality with morphological and biochemical features of necrosis and apoptosis (18) (19) . Host cell death by pyroptosis contributes to the control of microbial infection such as salmonella, shigela, listeria, pseudomonas, franscisella and legionella (18) (19) . Pyroptosis is also caused by stroke and cancer therapy (20) . Along with the pyroptotic program, a connected interplay of biochemical and morphological events causes the formation ofpores (1-2 nm) in the plasma membrane, which leads to potassium efflux, water influx, cell swelling, and rupture of plasma membrane and release of intracellular contents (20) . It has been shown that during pyroptosis, caspase-l and likely caspase-7 (21) act together in the proteolytic digestion of several types of proteins including chaperone HSP-90, y-actin, ataxin-3, HnRNP-A2, and the glycolysis enzymes glyceraldehyde-3phosphate dehydrogenase, enolase, pyruvate kinase, among others proteins (22) . Because some caspase-l substrates are also caspase-3 substrates, more studies are need to identify which caspase-l substrates have the ability to induce pyroptosis features.
Most cells infected by bacteria, for example, shigella and legionella, viruses and protozoan may also undergo autophagy, a cellular process involved in aberrant proteins and damaged organelle degradation by hydrolases into the lysosomes (23) . Autophagy playa role in a wide variety of normal physiological processes including energy metabolism, organelle turnover, growth regulation, aging and cellular selfdigestion during starvation and hormone deprivation (23) . During this process, organelles such as the mitochondria, endoplasmic reticulum and protein aggregates are first enwrapped in double membrane vesicles, named autophagosomes, which delivery their content to endosomes and later to lysosomes. The formation ofautophagic vacuoles is mediated by more then 30 autophagy-related proteins codified by Atg genes, which were first identified in yeast (24) . The transition from diffuse cytosolic to punctuate pattern of the lipidated form ofLC3 (Atg8) is used as one of the most reliable autophagy markers (24) (25) . Notably, the membrane trafficking events required for autophagy also participate in pathogen delivery into the lysosome and into endosomal compartments containing the Toll-like receptors, such as TLR3, 7, 9 and 10. The formation of these complexes leads to activation of type I interferon signaling as well as delivery of endogenously synthesized viral antigens to MHCII-processing and -loading compartments (25) . Therefore, autophagic cells are likely to instigate the biochemical events leading to innate and adaptive responses.
TNF receptor platforms controlling inflammatory, apoptosis and necrosis cell death pathways
The TNF family of cytokines play an important role in immunity and inflammation (26) . The many biological actions of TNF-o. are initiated after its binding to death receptors (DRs) and the formation of signal-induced multi-complex platforms known as DISC (death-inducing signaling complex) at plasma membrane (complex I) and within the cytoplasm (complex II). Depending on certain conditions, TNF can induce either the expression of pro-inflammatory genes via NF-KB pathways, or cellular demise as apoptosis and necrosis cell program, or proliferation and differentiation. The exact interplay of signaling pathways and the number of components involved in these signal-induced multi-protein complexes are now being distinguished, but not yet fully understood (26) . It is known that these interactions and downstream signaling pathways can be inhibited by either inhibitors of apoptosis protein (lAPs): X chromosome-linked lAP (XIAP), clAPl and clAP2, or protease-dead caspase-8 homologue (cFLIP) (l0, 26) and up-regulating the expression ofBcl-2 family member (27) .
Binding of TNF-a to TNFRI (complex I) leads to the recruitment of the TNFR I-associated death domain (TRADD) protein and subsequent recruitment of the adaptor proteins: FAS-associated factor (FADD) protein, TNF-receptor associated factor 2 and 5 (TRAF 2/5), cellular inhibitor of apoptosis protein 1 and 2 (clAP-l/2) and RIPI (28) . The association of TRAF2/5 and RIPI with TRADD activates Janus kinase (JNK), p38 kinase and TAKl/TAK2/3 complex. TAKl activates IKK/ NEMO complex, which in tum phosphorylates NF-KB inhibitor to the protein IKB, which is then ubiquitinated by the SCFj3/TrCP E3 ubiquitin ligase and subsequently degraded in the proteasomes. The NF-KB subunits p65, p50 and IKBa are also cleaved by caspases, and novel N-and C-terminal fragments enter directly into the proteasomes where they are fully degraded (29) . Once released from the complex, NF-KB moves to the nucleus to promote the transcription of the pro-inflammatory genes (10) . NF-KB is a transcriptional activator of many antiapoptotic genes including c-FLIP, c-lAP -1, c-lAP-2, XIAP, Bcl-xL, GADD45, and superoxide dismutase 2 (l0, 26).
While the interaction of the TNF-Rl with either FADD or pro-caspase-8 and -10, via both DD and DED (death effector domain) triggers the apoptotic signaling cascade, the interaction with negative regulator cFLIP will block this apoptotic signaling cascade, leading to cellular survival and Nf-xls-mediated pro-inflammatory response (26, 28) . Activation of caspase-8 or -10 within either TNFR complex I or II propagates the activation of effector caspases: caspase-3, -6 and -7, which then cause cellular destruction without mitochondria participation (known as type I intrinsic pathway).
More commonly, the apoptotic signals are amplified by the release of mitochondrial apoptogenic factors: cytochrome c, Smac/Diablo (second mitochondrial-derived activator of caspase/ direct lAP-binding protein with low pI), a protein that binds to lAPs and blocks their caspase inhibitory activity, HtrA2/0mi, a mitochondrial serine protease, endonuclease G (EndoG) and apoptosisinducing factor (AIF) through mitochondrial death decision pores (30) . In this pathway, known as the type II extrinsic pathway, a pro-apoptotic molecule, such as BH3-interacting-domain death agonist (BID) is cleaved by caspases. Truncated 18ID relocalizes to the outer mitochondrial membrane and interacts with the multidomain BCL-2 family members: BCL-2-associated X protein BAX and BCL-2 antagonist/killer BAK, which are released from the BCL-2 anti-apoptotic proteins such as Bcl-2, Bcl-xL and MCL-l (27) . Insertion and oligomerization of activated BAX and BAK cause outer-membrane permeabilization (MOMP), initial cytocrome c release from the intermembrane space. This may be also followed by the loss of mitochondrial membrane potential, oxidati ve stress and the opening of the inner membrane permeability transition pore (PTP) which cooperates in the release of last pool of cytocrome c and other apoptogenic factors from the matrix (27, 30) . Cytochrome c interacts with apoptotic-protease activating factor 1 (APAF1) and caspase-9 to form a heptameric complex known as apoptosome, which results in the caspase-9 activation. Smac/Diablo induces the autodegradation of clAPs and activation of caspase-8. Different types of DNA damage exist that activate p53 and the p53-induced protein with a death domain protein (PIDD) to form a platform with caspase-2, called PIDDsome, leading to caspase-2 activation, that acts upstream of the mitochondria by promoting mitochondrial membrane permeabilization (26) . A coordinated cleavage of hundreds of substrates by the effectors caspases leads to morphological and functional hallmarks unique to the apoptotic process (27, (29) (30) .
The discovery that the inactivation of caspases proteolytic activity by pan-inhibitor Z-VAD-fmk and kinase activity of RIP 1 by necrostatin-l (31) strongly sensitizes cell to TNF-a, TRAIL and Fasinduced necroptosis opened a new way to identify genes involved in the necrosis cell death program (32) (33) . The necrotic cell death occurs upon the assembly of a large, signal-induced multiprotein complex containing caspase-8, FADD, RIPI and RIP3, which is now called necrosome. Activation of RIP 1 and RIP3 kinases in the complex initiates the cascade of phosphorylation of several target proteins including phospholipase A2, the proteases calpains and cathepsins, the cytoplasmatic NOXA1INADPH oxidase complex, the mitochondrial complex I, thereby leading to excessive ROS production, ATP depletion and opening of the mitochondrial permeability transition pores (34) . These events are accompanied by prolonged JNK activation and RIP3induced stimulation of glycolysis, glycogenolysis and glutaminolysis as well as the stimulation of Krebs cycle (32, 34) . Programmed necrotic cell death occurs under various pathological processes such as ischemic brain injury, myocardial infarction, organ transplantation and virus replication and clearly benefits the organism by priming the immune response (31, 35) . Nonetheless, excessive necrosis is detrimental to the host and may lead to death.
Necrotic cells release intracellular contents from organelles and nucleus (RNA, DNA, nucleotides) as well as DAMPs suchasHMGBl and HSPs that recruit and activate neutrophils, DCs and macrophages, thereby promoting a highly inflammatory process (9, 36) Moreover, necrotic cells actively secrete IL-l a and IL-6 (8-9). On the other hand, apoptotic cells expose ecto-CRT, phosphatidylserine, HSP70, HSP90, opsonins, thrombospondin, HMGBI (e.g. during secondary necrosis) and other molecules that serve as eat me signals for professional APCs and monocytes and macrophage recognition and engulfment (36) . This controlled process of apoptotic cell clearance is accompanied by the release of transforming growth factor-Bl (TGF-l3l) and PGE z which exert suppressive effects on most immune cells (8) (9) 36) .
Although autophagy may not be a modality of cell death, many stimuli that activate apoptosis induce autophagy, whereas signals that inhibit apoptosis inhibit autophagy (23) (24) . The pan caspase inhibitor Z-VAD-fmk inhibits caspases, but also blocks lysosomal cathepsins and hence cell death by autophagy. Anti-apoptotic proteins, such as Bcl-2 family members, bind to and inhibit beclin (Atg 6), and pro-apoptotic factors, such as BH3only proteins, disrupt this inhibitory interaction and thereby activate autophagy or vice-versa (25) . Autophagy is triggered by ROS derived from either the mitochondrial electron transport chain or NAPDH oxidases. Autophagy ofdamaged mitochondria limits ROS-modulated caspase-l activation and seems to negatively regulate pyroptosis (20) . Therefore, there are many lines of evidence connecting cell death and magnitude and duration of inflammatory process. With further understanding of the interplay between these diverse signaling pathways leading to cell death, we will be able to validate new targets for the control of cell death and thereby the innate and adaptive responses.
Finally, the mechanisms that regulate selective targeting of TNF receptors and their adaptors as well as the IKKINEMO complex are not yet fully understood (10, 26) . The suppressor of cytokine signaling (SOCS) family of proteins is a well known intracellular inhibitor ofNF-KB signaling and potential regulators of the cytokine production (37) . SOCSI binds to the p65 subunit of NF-KB and induces its degradation via the proteasome, whereas SOCS3 inhibits NF-KB activation by inhibiting the association between TAKI and TRAF6 (10) . Nonetheless, overall evidence suggests that degradation induced by both caspases and proteasomes undoubtedly serves as a critical regulatory step in defining between either apoptotic or necrotic pathways and inflammatory/ anti-apoptotic NF-KB pathway (10, 26, (29) (30) . Therefore, crystallographic and mechanistic structural insight into caspase itself and caspase bound to their substrates, approaches the inhibition ofcaspase-driven proteolysis, such as peptides, small molecules, and will provide possible means by which to interfere with inflammation in the near future. Likewise, inhibition of the immunoproteasomes, E3 ubiquitin ligases and deubiquitinating enzymes (DUBs) with peptides and small molecules may be useful for effective control of the inflammatory processes.
Conclusions andfuture directions
There are now many new options for controlling the immune system by targeting TLRs and NLRs family of receptors and their signaling pathways. Despite the diversity of ligands and interconnected pathways, future studies aimed at delineating common and unique structural features for receptors and ligand-receptor complex should provide some insights to their signal pathways in great detail. Therefore, monoclonal antibodies and small molecules in development that target single or groups of TLRs and NLRs will be important to improve vaccination against many pathogenic microbial products as well as improving anticancer therapy.
Apoptosis, necrosis, autophagy and pyroptosis are different modalities of immunogenic cell death that play critical roles in regulation of the immune system. Failure in the cell death program leads to either increased numbers of lymphocytes, increased number of infected phagocytic cells, auto-immune diseases, or an inability to dampen an immune response and malignancy. We have learned recently that several microbial products (PAMPs) and endogenous mediators (DAMPs) released from dying cells cooperate with cytokines IL-l a, IL-~, TNF -a, TRAIL, FAS, IFNs, IL-8 and IL-12 in augmenting innate response to microbe antigens and tumor immunogenic response. Processing and activation of caspases is one ofthe key downstream signaling events leading to pro-inflammatory responses, proliferation or killing of infected cells. In particular, studies on therapeutic targeting of caspase-l, a major regulator of inflamassomes and pyroptosis, and caspase-8, a major regulator of NF-KB activation, necrosis and apoptosis, constitute promising new approaches for the treatment of infections and inflammatory diseases as well as cancers.
